Analysts See $0.34 EPS for Heska Corporation (HSKA)

September 30, 2018 - By Jason Dias

Investors sentiment increased to 1.76 in Q2 2018. Its up 0.84, from 0.92 in 2018Q1. It is positive, as 9 investors sold Heska Corporation shares while 33 reduced holdings. 24 funds opened positions while 50 raised stakes. 6.27 million shares or 3.58% more from 6.05 million shares in 2018Q1 were reported.
Arizona State Retirement System holds 9,733 shares. Raymond James And Assocs stated it has 106,237 shares. D E Shaw And Incorporated invested in 4,820 shares or 0% of the stock. California Public Employees Retirement has 0% invested in Heska Corporation (NASDAQ:HSKA) for 7,376 shares. Oppenheimer Asset Mngmt has 0.01% invested in Heska Corporation (NASDAQ:HSKA). Secor Cap Advsr Limited Partnership accumulated 6,823 shares. Geode Cap Mgmt Limited accumulated 67,096 shares or 0% of the stock. State Teachers Retirement stated it has 0% in Heska Corporation (NASDAQ:HSKA). Kentucky-based Teachers Retirement Sys Of The State Of Kentucky has invested 0% in Heska Corporation (NASDAQ:HSKA). Quantitative Systematic Strategies Limited reported 0.05% in Heska Corporation (NASDAQ:HSKA). Art Advsr Ltd Com has invested 0.02% in Heska Corporation (NASDAQ:HSKA). The Quebec – Canada-based Sector Pension Inv Board has invested 0% in Heska Corporation (NASDAQ:HSKA). Fiera Cap has invested 0.02% of its portfolio in Heska Corporation (NASDAQ:HSKA). Texas Permanent School Fund invested in 0.01% or 4,333 shares. Guggenheim Cap Ltd Liability Co reported 0% stake.

Since May 18, 2018, it had 0 insider purchases, and 18 insider sales for $9.36 million activity. GORDON G IRWIN also sold $359,613 worth of Heska Corporation (NASDAQ:HSKA) on Wednesday, June 6. 5,000 shares were sold by Trowbridge Bonnie J., worth $505,038. $278,750 worth of Heska Corporation (NASDAQ:HSKA) was sold by NAPOLITANO JASON A on Thursday, September 13. 750 shares were sold by Wisnewski Nancy, worth $79,875 on Friday, June 8. $291,743 worth of Heska Corporation (NASDAQ:HSKA) was sold by Lippincott Rod on Thursday, August 23. On Friday, May 18 Eyl Steven M. sold $59,946 worth of Heska Corporation (NASDAQ:HSKA) or 582 shares.

Analysts expect Heska Corporation (NASDAQ:HSKA) to report $0.34 EPS on November, 1.They anticipate $0.06 EPS change or 15.00 % from last quarter’s $0.4 EPS. HSKA’s profit would be $2.55 million giving it 83.32 P/E if the $0.34 EPS is correct. After having $0.24 EPS previously, Heska Corporation’s analysts see 41.67 % EPS growth. The stock increased 3.04% or $3.34 during the last trading session, reaching $113.31. About 38,118 shares traded or 3.20% up from the average. Heska Corporation (NASDAQ:HSKA) has risen 12.43% since September 30, 2017 and is uptrending. It has underperformed by 3.19% the S&P500.

Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company has market cap of $849.58 million. It operates through two divisions, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. It has a 145.46 P/E ratio. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps.

Another recent and important Heska Corporation (NASDAQ:HSKA) news was published by which published an article titled: “Canaccord bullish on medical diagnostic firms” on September 14, 2018.

Heska Corporation (NASDAQ:HSKA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: